RE: RE: Zacks?« If you think there is too muchPUMPING on this stock - it can only mean one thing - YOU HAVEN'T DONEENOUGH RESEARCH AND DUE DILIGENCE. “
What asilly statement. Now then, let’s look at your ‘pumping’:
“Scans most always find areas ofconcern on the lung - then it's up to the Specialist to subjectively decidewhether it warrants biopsy or not..”
And why do you thinkthat is “unacceptable”? That’s what MD’s are trained for! That’s what they aredoing right now and will do in the future. Yes, they use all kind of medicaldevices for their analysis, but those devices deliver data and the MD evaluatesthe data and makes a diagnosis. MRI,EKG, ECG - you name it. All deliver data, MD does diagnosis. And that will notchange with the Aura. Forget the ‘green light good – red light bad’ idea being promoted.Not going to fly with any MD, they simply will not buy it. What they will buyis a device which will give them a probability reading. And that’s what it willbe. And that means the market is limited to the specialist. The Verisantepromotional machine suggests this will be a screening device standing in everyGP’s office. Maybe in five years after many more studies and much more moneyspent.
“the COREreduced these false positives by over 75% - this is huge!!!”
Yes it is but what you avoid to mention isthat it goes along with a reduction in the detection sensitivity. Means you miss cancerous lesions you wouldhave not missed before. Which comes down to that: “Great we spared you five biopsies.But we might have missed your cancer.” Whereas now it is: “We will have to dosix biopsies on you but will know if you have cancer or not.” Which would yourather hear as a patient?